This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Pharma Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Nobuaki Hamato: Innovator in Virus-Free Plasma Protein Compositions
Introduction
Nobuaki Hamato is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of plasma protein compositions, particularly in developing methods to ensure their safety from viral contamination. His innovative work has the potential to enhance the safety of medical treatments involving plasma proteins.
Latest Patents
Nobuaki Hamato holds a patent for "Virus-free plasma protein compositions treated with porous membrane and process for producing the same." This invention addresses the critical issue of viral contamination in plasma protein compositions. By utilizing a porous membrane treatment, his method efficiently removes contaminant viruses while preserving the activity of the proteins. The process involves a fractionation treatment by precipitation before the porous membrane treatment, resulting in a fibrinogen composition that is substantially free of non-enveloped viruses, including Parvovirus. This advancement allows for the convenient provision of safe plasma protein preparations free of viruses.
Career Highlights
Nobuaki Hamato is associated with Mitsubishi Pharma Corporation, where he continues to innovate in the field of pharmaceutical sciences. His work has garnered attention for its practical applications in improving the safety of medical products derived from human plasma. With a focus on addressing viral contamination, his contributions are vital to the healthcare industry.
Collaborations
Nobuaki has collaborated with notable colleagues, including Muneo Tsujikawa and Takeru Urayama. Their combined expertise has furthered the development of safe plasma protein compositions, enhancing the overall impact of their research.
Conclusion
Nobuaki Hamato's innovative work in virus-free plasma protein compositions represents a significant advancement in medical safety. His contributions not only address critical health concerns but also pave the way for safer medical treatments. His dedication to improving healthcare through innovation is commendable and impactful.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile